Royal Philips and the ZorgSaam Hospital announced the signing of a 15-year strategic partnership agreement, through which Philips will provide ZorgSaam with a wide range of integrated solutions for the diagnosis and treatment of patients in the region of Zeeland-Flanders in the southwest of the Netherlands. Philips will deliver diagnostic imaging and image-guided therapy solutions, as well as healthcare informatics, …

Community Health Systems, Inc. announced that an affiliate of the Company has signed a definitive agreement to sell three Tennessee hospitals – 225-bed Tennova Healthcare-Dyersburg Regional in Dyersburg, 150-bed Tennova Healthcare-Regional Jackson in Jackson and 100-bed Tennova Healthcare-Volunteer Martin in Martin – and their associated assets to West Tennessee Healthcare. The transaction is expected to close in the second quarter …

Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution. This proprietary technology is currently in early-stage development for total and partial knee replacement, and the Johnson & Johnson Medical Devices Companies plan to broaden its application for a range of …

Photocure ASA, announced that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Light Cystoscopy (BLC™) with Cysview® to include Flexible Cystoscopes, which are used in the ongoing surveillance of patients with bladder cancer. This is the only combination of drug and device approved for the detection of bladder …

LivaNova PLC announced it has entered into an agreement to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions (“TandemLife”). The Pittsburgh-based company offers four product systems, all built around a common pump and controller. These systems, which include ExtraCorporeal Life Support (“ECLS”) and Percutaneous Mechanical Circulatory Support (“pMCS”), are complementary to LivaNova’s strong offerings in …

French healthcare group Sanofi has agreed to buy U.S. peer Bioverativ for $11.6 billion, in a deal which Sanofi said would boost its earnings and strengthen its presence in the field of treatment for rare diseases. Sanofi has agreed to buy all of the outstanding shares of Bioverativ for $105 per share in cash, marking a premium of 64 percent …

Cardiovascular Systems, Inc. announced two new partnerships broadening the company’s product portfolio. CSI is now the exclusive U.S. distributor of OrbusNeich balloon products. Additionally, the company has signed an original equipment manufacturer (OEM) agreement with Integer Holdings Corporation for CSI-branded ZILIENT™ guidewires. Scott Ward, CSI’s Chairman, President and Chief Executive Officer, said, “We intend to build on our market-leading position …

Laminate Medical Technologies announced the launch of its FDA pivotal study in the US. The first surgeries were performed by Dr. Jason Burgess and Dr. Paul Orland at the Carolinas Medical Center-Mercy, Charlotte, North Carolina. “We are excited to be the first site that enrolled patients in the US. The device was easy to implant and I am happy with …

PMD Solutions announced its successful enrolment in the NHS Innovation Accelerator (NIA) Programme as part of the NIA’s official kick-off launch event which took place in London this week. Now entering its third year, the NIA is an NHS England initiative delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs) and focused exclusively on identifying and partnering with …

PMD Solutions announced its successful enrolment in the NHS Innovation Accelerator (NIA) Programme as part of the NIA’s official kick-off launch event which took place in London this week. Now entering its third year, the NIA is an NHS England initiative delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs) and focused exclusively on identifying and partnering with …